Skip to content
10-Q

Quarterly Report

HAEMONETICS CORPORATION HAE

0000313143-25-000012

← back to feed
Filed
Feb 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Feb 3, 2025 50.24M sh
Long Term Debt Q3 2025 · Dec 28, 2024 $1.22B
Long Term Debt Q3 2025 · Mar 30, 2024 $797.56M
Cash And Equivalents Q3 2025 · Dec 28, 2024 $320.85M
Cash And Equivalents Q3 2025 · Mar 30, 2024 $178.8M
Current Liabilities Q3 2025 · Dec 28, 2024 $253.23M
Current Liabilities Q3 2025 · Mar 30, 2024 $300.38M
Current Assets Q3 2025 · Dec 28, 2024 $1.01B
Current Assets Q3 2025 · Mar 30, 2024 $768.9M
Total Assets Q3 2025 · Dec 28, 2024 $2.53B
Total Assets Q3 2025 · Mar 30, 2024 $2.2B
Shares Diluted Q3 2025 · Dec 30, 2023 51.45M sh
Shares Diluted Q3 2025 · Dec 30, 2023 51.39M sh
Stock Repurchased Q3 2025 · Dec 30, 2023 $0
Capex restated Q3 2025 · Dec 30, 2023 $31.44M
Operating Cash Flow Q3 2025 · Dec 30, 2023 $117.67M
Stockholders Equity Q3 2025 · Dec 30, 2023 $943.32M
Stockholders Equity Q3 2025 · Sep 30, 2023 $893.66M
Stockholders Equity Q3 2025 · Jul 1, 2023 $864.62M
Stockholders Equity Q3 2025 · Apr 1, 2023 $818M
Eps Diluted Q3 2025 · Dec 30, 2023 $0.61
Eps Diluted Q3 2025 · Dec 30, 2023 $1.89
Eps Basic Q3 2025 · Dec 30, 2023 $0.62
Eps Basic Q3 2025 · Dec 30, 2023 $1.92
Sga Expense Q3 2025 · Dec 30, 2023 $111.71M
Sga Expense restated Q3 2025 · Dec 30, 2023 $320.52M
Rd Expense Q3 2025 · Dec 30, 2023 $13.27M
Rd Expense Q3 2025 · Dec 30, 2023 $38.58M
Net Income Q3 2025 · Dec 30, 2023 $31.24M
Net Income Q3 2025 · Dec 30, 2023 $97.19M
Net Income Q3 2025 · Sep 30, 2023 $24.91M
Net Income Q3 2025 · Jul 1, 2023 $41.04M
Operating Income Q3 2025 · Dec 30, 2023 $45.98M
Operating Income Q3 2025 · Dec 30, 2023 $134.94M
Gross Profit Q3 2025 · Dec 30, 2023 $177.87M
Gross Profit Q3 2025 · Dec 30, 2023 $515.64M
Cost Of Revenue Q3 2025 · Dec 30, 2023 $158.38M
Cost Of Revenue Q3 2025 · Dec 30, 2023 $450.12M
Revenue Q3 2025 · Dec 30, 2023 $336.25M
Revenue Q3 2025 · Dec 30, 2023 $965.77M